Abstract

ASPIRIN AND ORAL PREDNISOLON VS ASPIRIN PLUS HEPARIN IN THE TREATMENT OF FEMALE WITH REPETITIVE MISCARRIAGE(2017–2020)

Dr. Dhifaf H. Majeed*, Dr. Hawraa M. Naas and Dr. Suad Saddam Salih

ABSTRACT

Background: recurrent pregnancy loss (RPL) is defined as at least two or three sequential abortions before the 20th week of gestation. RPL occurs in 1% to 5% of all pregnancies. Aim of the Work: to assess the efficacy of low dose aspirin and steroids therapy versus Aspirin and heparin LMWH Study in the management of women with recurrent miscarriage. Patients and Methods: this randomized clinical trial was conducted in the repeated miscarriage clinics in the Obstetrics and Gynecology Department, in Iraqi Hospital on 150 pregnant women, who fulfilled the inclusion criteria and after taking an informed consent. Group 1: included 75 pregnant females administered with low dose aspirin 75 mg tablet (one tablet twice daily) and prednisolone 5mg two tablets twice daily (20mg). Group 2: included 75 pregnant females administered with low dose aspirin 75 mg tablet (one tablet twice daily) and heparin. Both groups were followed in hospital recurrent miscarriage clinic every two weeks by ultrasonography from the incidence of the pregnancy till delivery. Results: women treated with prednisolone (PSL) plus LDA had a 32.2% higher live birth rate than group II and according to on-going pregnancy data was in group I 37/50(74%) and in group II 21/50(42%) OR (C.I. 95% 4.128 [2.142-7.952] RR (C.I. 95%1.875 [1.401-2.505] p

Keywords: Aspirin, Steroids, Unexplained Recurrent Miscarriage, heparin LMWH.